Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001623632-17-001520
Filing Date
2017-07-10
Accepted
2017-07-10 13:59:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 form.htm SC 13G/A 102504
2 GRAPHIC image_001.jpg GRAPHIC 64828
3 GRAPHIC image_002.jpg GRAPHIC 60203
  Complete submission text file 0001623632-17-001520.txt   276861
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 17957293
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address FEDERATED INVESTORS TOWER 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address FEDERATED INVESTORS TOWER 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED INVESTORS INC /PA/ (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice